| Product NDC: | 55154-5465 |
| Proprietary Name: | Captopril |
| Non Proprietary Name: | Captopril |
| Active Ingredient(s): | 25 mg/1 & nbsp; Captopril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-5465 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074434 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110429 |
| Package NDC: | 55154-5465-0 |
| Package Description: | 10 BLISTER PACK in 1 BAG (55154-5465-0) > 1 TABLET in 1 BLISTER PACK |
| NDC Code | 55154-5465-0 |
| Proprietary Name | Captopril |
| Package Description | 10 BLISTER PACK in 1 BAG (55154-5465-0) > 1 TABLET in 1 BLISTER PACK |
| Product NDC | 55154-5465 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Captopril |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110429 |
| Marketing Category Name | ANDA |
| Labeler Name | Cardinal Health |
| Substance Name | CAPTOPRIL |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |